<SEC-DOCUMENT>0001493152-24-018166.txt : 20240508
<SEC-HEADER>0001493152-24-018166.hdr.sgml : 20240508
<ACCEPTANCE-DATETIME>20240508081554
ACCESSION NUMBER:		0001493152-24-018166
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20240503
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240508
DATE AS OF CHANGE:		20240508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Imunon, Inc.
		CENTRAL INDEX KEY:			0000749647
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				521256615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15911
		FILM NUMBER:		24924358

	BUSINESS ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648
		BUSINESS PHONE:		(609) 896-9100

	MAIL ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Celsion CORP
		DATE OF NAME CHANGE:	20071121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELSION CORP
		DATE OF NAME CHANGE:	19980515

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEUNG LABORATORIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:IMNN="http://imunon.com/20240503">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_IMNN_imunon.com_20240503 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20240503_20240503 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0000749647 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-05-03" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-05-03" id="Fact000004" name="dei:EntityCentralIndexKey">0000749647</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="imnn-20240503.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-05-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-03</xbrli:startDate>
        <xbrli:endDate>2024-05-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90D_edei--DocumentType_c20240503__20240503_zLOM5ZnYx9I9"><ix:nonNumeric contextRef="AsOf2024-05-03" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of The Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (Date of earliest event reported): <span id="xdx_903_edei--DocumentPeriodEndDate_c20240503__20240503_zgHJzGT5weRh"><ix:nonNumeric contextRef="AsOf2024-05-03" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">May 3, 2024</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_908_edei--EntityRegistrantName_c20240503__20240503_zzteFCRbYEzj"><ix:nonNumeric contextRef="AsOf2024-05-03" id="Fact000011" name="dei:EntityRegistrantName">IMUNON,
INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its Charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityIncorporationStateCountryCode_c20240503__20240503_zr2jv1EjhOWc"><ix:nonNumeric contextRef="AsOf2024-05-03" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityFileNumber_c20240503__20240503_zkkToT0XfJp"><ix:nonNumeric contextRef="AsOf2024-05-03" id="Fact000013" name="dei:EntityFileNumber">001-15911</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20240503__20240503_zMoUkOw0Cxda"><ix:nonNumeric contextRef="AsOf2024-05-03" id="Fact000014" name="dei:EntityTaxIdentificationNumber">52-1256615</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
    or other jurisdiction</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
    incorporation)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Commission</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>File
    Number)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(IRS
    Employer</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
    No.)</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 74%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityAddressAddressLine1_c20240503__20240503_zpncqG1SV69c"><ix:nonNumeric contextRef="AsOf2024-05-03" id="Fact000015" name="dei:EntityAddressAddressLine1">997
    Lenox Drive</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressAddressLine2_c20240503__20240503_zuVoeP0zfySg"><ix:nonNumeric contextRef="AsOf2024-05-03" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 100</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressCityOrTown_c20240503__20240503_zKpuMvkFPl8j"><ix:nonNumeric contextRef="AsOf2024-05-03" id="Fact000017" name="dei:EntityAddressCityOrTown">Lawrenceville</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressStateOrProvince_c20240503__20240503_zET8WZJw7k08"><ix:nonNumeric contextRef="AsOf2024-05-03" id="Fact000018" name="dei:EntityAddressStateOrProvince">NJ</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressPostalZipCode_c20240503__20240503_zyt8a9GXpio1"><ix:nonNumeric contextRef="AsOf2024-05-03" id="Fact000019" name="dei:EntityAddressPostalZipCode">08648-2311</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address of principal
    executive offices)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Zip Code)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--CityAreaCode_c20240503__20240503_zPczQJIvtNIe"><ix:nonNumeric contextRef="AsOf2024-05-03" id="Fact000020" name="dei:CityAreaCode">(609)</ix:nonNumeric></span>
<span id="xdx_90E_edei--LocalPhoneNumber_c20240503__20240503_zjGu9ubj2eM8"><ix:nonNumeric contextRef="AsOf2024-05-03" id="Fact000021" name="dei:LocalPhoneNumber">896-9100</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Registrant&#8217;s
telephone number, including area code)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N/A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Former
name or former address, if changed since last report.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--WrittenCommunications_c20240503__20240503_z2ztFkLUWc2i"><ix:nonNumeric contextRef="AsOf2024-05-03" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the
    Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--SolicitingMaterial_c20240503__20240503_zv1Koz2xyNk4"><ix:nonNumeric contextRef="AsOf2024-05-03" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the
    Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementTenderOffer_c20240503__20240503_z6eIrgdtd9q5"><ix:nonNumeric contextRef="AsOf2024-05-03" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b)
    under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--PreCommencementIssuerTenderOffer_c20240503__20240503_zBvnncV3nGgd"><ix:nonNumeric contextRef="AsOf2024-05-03" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c)
    under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--Security12bTitle_c20240503__20240503_zAKiappBsMne"><ix:nonNumeric contextRef="AsOf2024-05-03" id="Fact000026" name="dei:Security12bTitle">Common stock, par value
    $0.01 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--TradingSymbol_c20240503__20240503_zOK4QbkjSn76"><ix:nonNumeric contextRef="AsOf2024-05-03" id="Fact000027" name="dei:TradingSymbol">IMNN</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_908_edei--SecurityExchangeName_c20240503__20240503_z5AVY4JvqWE6"><ix:nonNumeric contextRef="AsOf2024-05-03" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933
(&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20240503__20240503_zRxrM7RfaF95"><ix:nonNumeric contextRef="AsOf2024-05-03" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 5.02</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Departure of Directors
    or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 8, 2024, Imunon, Inc. (the &#8220;Company&#8221;) announced the appointment of Stacy R. Lindborg, Ph.D., as President and Chief Executive
Officer of the Company, effective as of May 13, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Lindborg (age 53) has served on the Company&#8217;s Board of Directors since June 2021. Dr. Lindborg, a globally recognized biostatistician,
has nearly 30 years of pharmaceutical and biotech industry experience with a particular focus on R&amp;D, regulatory affairs, executive
management and strategy development. She has worked with biologics, small molecules and cell therapies to address a range of diseases
and disorders. She has extensive experience in early-stage development, having taken molecules from first-in-human studies into the clinic,
through regulatory approval and commercial launch. Until May 9, 2024, Dr. Lindborg is co-Chief Executive Officer at Brainstorm Cell Therapeutics
Inc. (Nasdaq: BCLI), which she joined in 2020. From 2012 to 2020, she held positions of increasing responsibility at Biogen, where she
worked in biostatistics and biometrics and served as Vice President, Analytics and Data Science, building a world-class analytics and
data sciences team that was responsible for global data as well as statistical and epidemiological support for R&amp;D and marketed products.
Prior to her time at Biogen, Dr. Lindborg had worked at Eli Lilly and Company (NYSE: LLY) since 1996, advancing through the organization
to serve from 2010 to 2012 as Head of R&amp;D Strategy with responsibility for characterizing the productivity of the portfolio and advancing
key R&amp;D strategy projects by connecting individual drug-development decisions to portfolio risk practices and driving fundamental
R&amp;D decisions to increase the number of drug launches. Dr. Lindborg received an M.A. and a Ph.D. in statistics from Baylor University.
She has authored more than 50 abstracts, 200 presentations and 40 manuscripts that have been published in peer-reviewed journals. She
has held numerous positions within the American Statistical Association and International Biometric Society and was elected Fellow in
2008.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no family relationship between Dr. Lindborg and any other director or executive officer of the Company. There are no transactions
between the Company and Dr. Lindborg disclosable pursuant to Item 404(a) of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with her appointment as President and Chief Executive Officer, on May 3, 2024, Dr. Lindborg entered into an employment agreement
(the &#8220;Employment Agreement&#8221;) with the Company, with her employment to be effective as of May 13, 2024. Pursuant to the Employment
Agreement, the Company will pay Dr. Lindborg an initial salary of $567,000 and a targeted annual performance bonus of 100% of her annual
base salary. Dr. Lindborg will also receive (i) an option to purchase 112,500 shares of the Company&#8217;s common stock pursuant to
the Company&#8217;s 2018 Stock Incentive Plan (the &#8220;Stock Plan&#8221;) and (ii) an additional option to purchase 112,500 shares
of the Company&#8217;s common stock under the Stock Plan following the Company&#8217;s 2024 annual meeting of stockholders, subject to
Dr. Lindborg remaining employed in good standing on such date. Both stock options will vest in equal fourths over four years, with the
first 28,125 options vesting on the first anniversary of the date of grant and the remaining three-fourths vesting in equal parts on
subsequent anniversaries of the grant date. Dr. Lindborg is also eligible to receive a sign-on bonus from the Company of $200,000, subject
to certain conditions. Dr. Lindborg&#8217;s initial term of employment pursuant to the Employment Agreement is one year, to be extended
automatically by an additional year at the end of such term and each subsequent one-year term absent three months&#8217; prior written
notice by Dr. Lindborg or the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Employment Agreement does not purport to be complete and is qualified in its entirety by the full text of
the Employment Agreement, a copy of which is attached to this Current Report on Form 8-K as exhibit 10.1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 7.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulation FD Disclosure</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the Company&#8217;s press release announcing Dr. Lindborg&#8217;s appointment as President and Chief Executive Officer is furnished
and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange
Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing
under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">Exhibits</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Employment Agreement, dated as of May 3, 2024, between Imunon, Inc. and Stacy Lindborg, Ph.D.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press release dated May 8, 2024</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the
    inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IMUNON, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: May 8, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ Jeffrey
    W. Church</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey W. Church</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President, Chief Financial Officer and
    Corporate Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjVEKwkAMRE/QO4T9ltquFqF/WlTEKlJE/F1tlMV2U7Jr1SN5S9cWMQRCmHkzQgzEkha6QobjrMhhj3VTKYdQ4AUZzRm9I1utU/C3wKu2jpVx3fsDM/IMeiYJpTx5obO22mKZQpQMo8lQjiGO01EC040IvnpG5qJLNE6rCpQpYcfUsEan+NUn7NWTDNWvruqAbDWZFOIw6uU3yCiWsKVWPYhvFvI8E8Ggm0Asme6Nd82fDs2XhHmFta+zPf3f4AP/g0qA -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EMPLOYMENT
AGREEMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
<B>EMPLOYMENT AGREEMENT</B> (the &ldquo;Agreement&rdquo;) is made and entered into effective as of the 3rd day of May, 2024 (the &ldquo;Effective
Date&rdquo;), by and between Imunon, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), and Stacy Lindborg, Ph.D., an individual
(the &ldquo;Executive&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WITNESSETH</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>the Company desires to retain the Executive to serve in the capacities of President and Chief Executive Officer of the Company on
the terms and conditions set forth in this Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Executive desires to commence employment in such capacities on such terms and conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the promises and the mutual covenants and agreements herein contained, and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged by the parties hereto, such parties, intending to be legally
bound, agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Employment
                                            Duties and Acceptance</U>.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            accordance with the terms of this Agreement, the Company hereby employs the Executive for
                                            the Employment Period (as hereinafter defined) to render full-time services to the Company
                                            as President and Chief Executive Officer and to perform the customary duties and bear the
                                            customary responsibilities of such positions and such other duties and responsibilities,
                                            commensurate with such positions, as the Executive shall be directed from time to time by
                                            the Board of Directors of the Company (the &ldquo;Board&rdquo;) to perform or bear, which
                                            duties and responsibilities shall be consistent with the provisions of the Amended and Restated
                                            Bylaws of the Company as in effect from time to time (the &ldquo;Bylaws&rdquo;) that relate
                                            to or bear upon the duties of a director or President and Chief Executive Officer.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Executive shall report to the Board and agrees to consult with, and take appropriate direction
                                            from, the Executive Chairman of the Board so long as the Chairman is an employee of the Company.
                                            Executive shall commence employment on May 13, 2024 or on the date immediately following
                                            any notice period required by her current employer (the &ldquo;Start Date&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            of the Effective Date, the Executive hereby accepts such employment and agrees to render
                                            the services described above, commencing on the Start Date, in accordance with the terms
                                            of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            addition to the roles and duties set forth above, the Executive will continue to serve in
                                            her role as a member of the Board for the remainder of her current elected term; <I>provided,
                                            however</I>, that the Executive will no longer be eligible to receive compensation related
                                            to Executive&rsquo;s service on the Board following her start date as an employee of the
                                            Company. With respect to future terms as a member of the Board, the Executive further agrees
                                            to accept election and to serve during all or any part of the Term as a director of the Company
                                            without any compensation therefor other than that specified in this Agreement, if elected
                                            to such position by the Board or the stockholders of the Company. At all times during the
                                            Term, the Company shall include the Executive in the management slate for election as a director
                                            at every stockholders&rsquo; meeting at which her term as a director would otherwise expire.
                                            At the request of the Board, following any termination of this Agreement by either party,
                                            or the expiration of this Agreement, the Executive promptly shall tender her resignation
                                            as a director of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            principal place of employment of the Executive hereunder shall at all times during the Term
                                            be in the Lawrenceville, New Jersey area or such other location(s) as may be mutually acceptable
                                            to the Executive and the Board.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                            anything to the contrary herein, although the Executive shall provide services as a full-time
                                            employee, it is understood that the Executive, with prior notification to the Board, may
                                            (A) (1) participate in non-competing professional activities (except as set forth in clause
                                            (B)); (2) publish academic articles; (3) support non-competing external research programs;
                                            (4) participate in community and/or philanthropic activities; and (5) serve on non-profit
                                            boards of directors; and (B) subject to the prior written consent of the Board, which consent
                                            shall not unreasonably be withheld, serve on non-competing for-profit boards of directors
                                            (collectively, &ldquo;Permitted Activities&rdquo;); <I>provided</I>, that such Permitted
                                            Activities do not interfere with the Executive&rsquo;s duties or services to the Company.
                                            As of the date of this Agreement, the Executive is engaged in the activities set forth on
                                            Exhibit A, which the parties agree are Permitted Activities.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Term
                                            of Employment</U>. The initial term of the Executive&rsquo;s employment under this Agreement
                                            (the &ldquo;Employment Period&rdquo;) shall commence on the Start Date and shall end on the
                                            first anniversary of the Start Date, unless sooner terminated by the Company or the Executive
                                            pursuant to Section 6 or 7 of this Agreement, as the case may be, or voluntarily by the Executive.
                                            Notwithstanding the foregoing, unless written notice is given by the Executive or the Company
                                            to the other at least three (3) months prior to the expiration of the Employment Period (including
                                            at least three (3) months prior to the expiration of any extension of the Agreement, as provided
                                            below), the Employment Period automatically shall be extended by one (1) year from the date
                                            it would otherwise end (whether upon expiration of the initial Term or any extension(s) thereof),
                                            unless sooner terminated pursuant to Section 6 or 7 hereof or voluntarily by the Executive.
                                            In the event of such an automatic extension, the term &ldquo;Employment Period,&rdquo; as
                                            used herein, shall include each and any such extension.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Compensation
                                            and Benefits</U>.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            compensation for the services rendered or to be rendered pursuant to this Agreement, the
                                            Company will pay the Executive an annualized base salary in the amount of $567,000 (the &ldquo;Base
                                            Salary&rdquo;). The Executive&rsquo;s Base Salary hereunder shall be reviewed by the Compensation
                                            Committee of the Board (the &ldquo;Compensation Committee&rdquo;) in the first quarter of
                                            2025, and at least annually thereafter during the Employment Period by the Compensation Committee
                                            or the Board, for adjustment upward (but not downward). Any adjustments shall be made at
                                            the discretion of the Board or the Compensation Committee. The Executive&rsquo;s Base Salary,
                                            as so adjusted, shall be considered the new Base Salary for all purposes of this Agreement.
                                            The Base Salary shall be paid in accordance with the Company&rsquo;s standard payroll practices
                                            applicable to its senior executives, as in effect from time to time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company agrees that the Executive shall be eligible for an annual performance bonus from
                                            the Company with respect to each fiscal year of the Company that ends during the Employment
                                            Period, pursuant to the Company&rsquo;s management incentive bonus program, policy or practice
                                            of the Board or Compensation Committee, as in effect from time to time. The target value
                                            of the annual performance bonus shall be 100% of the Executive&rsquo;s Base Salary, with
                                            a range of 0 to 100%. The amount of any such performance bonus shall be determined by the
                                            Board or the Compensation Committee in its sole and absolute discretion, consistent with
                                            the Company&rsquo;s performance, the Executive&rsquo;s contribution to the Company&rsquo;s
                                            performance and the provisions of any such applicable incentive bonus program, policy or
                                            practice; <I>provided, however</I>, that such annual performance bonus shall not exceed one
                                            hundred percent (100%) of the Base Salary for the fiscal year to which the bonus applies
                                            except pursuant to a specific finding by the Board or the Compensation Committee of the Board
                                            that a higher percentage is appropriate. Any such annual performance bonus shall be paid
                                            not later than three months after the end of the fiscal year to which the bonus relates;
                                            provided, however, that the Executive shall only be eligible to receive the annual performance
                                            bonus if the Executive is actively employed in good standing on the payment date. For the
                                            2024 fiscal year, the annual performance bonus, if any, will be prorated based on the Executive&rsquo;s
                                            start date with the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company agrees to grant to the Executive, during the Employment Period, at the time of its
                                            usual annual grant to employees for the applicable year, such options and/or other equity
                                            awards with respect to shares of the Company&rsquo;s common stock as the Board or the Compensation
                                            Committee of the Board shall determine.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also agrees to grant to the Executive, following the Effective Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            option to purchase 112,500 shares of the Company&rsquo;s common stock (the &ldquo;First Option&rdquo;)
                                            under the Company&rsquo;s 2018 Stock Incentive Plan, as amended from time to time (the &ldquo;Stock
                                            Plan&rdquo;). The First Option shall vest in equal fourths over four years with the first
                                            28,125 options vesting on the first anniversary of the date of grant, and the remaining three-fourths
                                            vesting in equal parts on subsequent anniversaries of the grant date.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company further agrees to grant an additional option to purchase 112,500 shares of the Company&rsquo;s
                                            common stock under the Stock Plan following the Company&rsquo;s 2024 Annual Shareholder Meeting
                                            (the &ldquo;Second Option&rdquo;), subject to the Executive remaining employed in good standing
                                            on such date. The Second Option shall vest in equal fourths over four years with the first
                                            28,125 options vesting on the first anniversary of the date of grant, and the remaining three-fourths
                                            vesting in equal parts on subsequent anniversaries of the grant date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            First Option and the Second Option shall be subject in all respects to the terms of the Stock
                                            Plan and the award agreements evidencing the awards.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company shall pay or reimburse the Executive for all reasonable expenses actually incurred
                                            or paid by the Executive during the Employment Period in the performance of services under
                                            this Agreement, upon presentation of expense statements or vouchers or such other supporting
                                            information as may reasonably be required pursuant to the standard policies of the Company
                                            in effect from time to time. The Executive agrees to promptly submit and document any reimbursable
                                            expenses in accordance with the Company&rsquo;s expense reimbursement policies to facilitate
                                            the timely reimbursement of such expenses. Additionally, the Executive shall receive a $12,000
                                            annual allowance to be used at the Executive&rsquo;s discretion. The allowance will be grossed
                                            up for tax purposes at the rate of 25%. Such allowance and related tax gross-up shall be
                                            paid not later than two and one-half months after the end of the year to which the allowance
                                            relates.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                            the Employment Period, the Executive shall be eligible to participate in any qualified and
                                            non-qualified savings and retirement plans, and other compensation and benefit plans and
                                            programs, including welfare and fringe benefit programs, that are generally made available
                                            by the Company to other senior executives of the Company, in each case in accordance with
                                            the eligibility and participation provisions of such plans and programs and as such plans
                                            or programs may be in effect from time to time.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            2024, the Executive shall be eligible for paid vacation of four (4) weeks, to be taken in
                                            accordance with and subject to the vacation policy of the Company. Starting in 2025, the
                                            Executive shall be eligible for paid vacation of five (5) weeks per calendar year, to be
                                            taken in accordance with and subject to the vacation policy of the Company in effect from
                                            time to time. In the event that Executive does not utilize all of her vacation in any calendar
                                            year, she may carry forward up to five (5) weeks (<I>i.e.</I>, twenty-five (25) days) for
                                            up to one (1) calendar year. Unused vacation days shall not otherwise accumulate.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
                                            will be eligible to receive a sign-on bonus (the &ldquo;Sign-On Bonus&rdquo;) in an amount
                                            and subject to such terms and conditions as are separately agreed by the Company and Executive.
                                            A Sign-On Bonus, if any, shall be paid to Executive in a single lump-sum no later than March
                                            15, 2025.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Confidentiality</U>.
                                            As a condition of employment under this Agreement, the Executive agrees to execute the &ldquo;Employee
                                            Proprietary Information and Ownership of Inventions Agreement&rdquo; annexed hereto as Exhibit
                                            B (the &ldquo;PIIA&rdquo;). The Executive specifically agrees that failure to deliver such
                                            executed PIIA to the Company within five (5) days of the Effective Date shall render this
                                            Agreement null and void, and the Company shall have no further obligations to the Executive.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Non-Competition,
                                            Non-Solicitation and Non-Disparagement</U>.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                            the Employment Period, the Executive shall not (1) provide any services, directly or indirectly,
                                            to any other business or commercial entity without the consent of the Board or (2) participate
                                            in the formation of any business or commercial entity without the consent of the Board; <I>provided,
                                            however</I>, that nothing contained in this Section 5(a) shall be deemed to prohibit the
                                            Executive from acquiring, solely as an investment, shares of capital stock (or other interests)
                                            of any corporation (or other entity) not exceeding two percent (2%) of such corporation&rsquo;s
                                            (or other entity&rsquo;s) then-outstanding shares of capital stock (or other interests) and,
                                            <I>provided further</I>, that nothing contained herein shall be deemed to limit the Executive&rsquo;s
                                            Permitted Activities pursuant to Section 1(f).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            this Agreement is terminated by the Company for Cause (as defined in Section 6(c)) or if
                                            the Executive terminates this Agreement other than in accordance with Section 7 or 8 hereof,
                                            or if the Executive is entitled to receive severance payments in connection with a termination
                                            of her employment in accordance with Section 8(c)(i) or 8(d)(i), then for a period of twelve
                                            (12) months following the date of termination the Executive shall not, in the United States,
                                            (1) provide any services, directly or indirectly, to any other business or commercial entity
                                            in the Company&rsquo;s Field of Interest (as defined in Section 11), (2) solicit any customers
                                            or suppliers of the Company, (3) attempt to persuade or encourage customers or suppliers
                                            of the Company not to do business with the Company and/or to do business with a competitor
                                            of the Company, (4) participate in the formation of any business or commercial entity engaged
                                            primarily in the Company&rsquo;s Field of Interest, or (5) directly or indirectly employ,
                                            or seek to employ or secure the services in any capacity of, any person employed at that
                                            time by the Company or any of its Affiliates (as defined in Section 11), or otherwise encourage
                                            or entice any such person to leave such employment; <I>provided, however</I>, that nothing
                                            contained in this Section 5(b) shall be deemed to prohibit the Executive from acquiring,
                                            solely as an investment, shares of capital stock (or other interests) of any corporation
                                            (or other entity) in the Company&rsquo;s Field of Interest not exceeding two percent (2%)
                                            of such corporation&rsquo;s (or other entity&rsquo;s) then outstanding shares of capital
                                            stock (or other interests) and, <I>provided further</I>, that nothing contained herein shall
                                            be deemed to limit Executive&rsquo;s Permitted Activities pursuant to Section 1(f). The Executive
                                            may request, in writing, that the Company waive its rights and/or the Executive&rsquo;s obligations
                                            under this Section 5(b) in connection with a specific matter or opportunity; <I>provided</I>,
                                            that the Company shall have sole discretion to determine whether to grant such a waiver and
                                            the terms of any such waiver, which, if granted, shall be communicated to the Executive in
                                            writing. If any such waiver is granted, the Executive agrees to comply fully with its terms.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                            no time during the Employment Period or thereafter will the Executive knowingly make any
                                            written or oral material untrue statement about the Company or its Affiliates or any written
                                            or oral statement that disparages the Company or its Affiliates. In addition, the Company
                                            will direct its executives and senior officers not to knowingly make any material written
                                            or oral untrue statement about the Executive or any written or oral statement that disparages
                                            the Executive.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Company has reason to believe that the Executive has committed a breach, or is threatening
                                            to commit a breach, of any of the provisions of this Section 5 or Exhibit B, the Company
                                            shall have the right and remedy to have the provisions of this Agreement or Exhibit B, as
                                            the case may be, specifically enforced, it being acknowledged and agreed that any such breach
                                            or threatened breach will cause irreparable injury to the Company and that money damages
                                            will not provide an adequate remedy to the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            any of the covenants contained in this Section 5 or Exhibit B or any part hereof or thereof,
                                            is hereafter construed to be invalid, illegal or unenforceable by a court or regulatory agency
                                            or tribunal of competent jurisdiction, such court, agency or tribunal shall have the power,
                                            and hereby is directed, to substitute for or limit such provision(s) in order as closely
                                            as possible to effectuate the original intent of the parties with respect to such invalid,
                                            illegal or unenforceable covenant(s) generally and so to enforce such substituted covenant(s).
                                            Subject to the foregoing, the invalidity, illegality or unenforceability of any one or more
                                            of the covenants contained in this Section 5 shall not affect the validity of any other provision
                                            hereof, which shall be given full effect without regard to the invalid portions.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            any of the covenants contained in this Section 5 or Exhibit B, or any part hereof or thereof,
                                            is held to be unenforceable because of the duration of such provision, the area covered thereby
                                            or the extent thereof, the parties agree that the tribunal making such determination shall
                                            have the power, and hereby is directed, to reduce the duration, area and/or extent of such
                                            provision and, in its reduced form, such provision shall then be enforceable.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Termination
                                            by the Company</U>. During the Employment Period, the Company may terminate this Agreement
                                            if any one or more of the following shall occur:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Executive shall die during the Employment Period; <I>provided, however</I>, that the Executive&rsquo;s
                                            legal representatives shall be entitled to receive (1) the Executive&rsquo;s Base Salary
                                            through the date which is ninety (90) days after the Executive&rsquo;s date of death and
                                            (2) a pro rata annual performance bonus (prorated by multiplying the full year bonus that
                                            otherwise would be due by the percentage derived from dividing the number of days in the
                                            then-current year prior to the death of the Executive by three-hundred sixty-five (365))
                                            with respect to the fiscal year of the Company during which death occurs. Such pro rata bonus
                                            shall be paid at the same time as such annual performance bonuses are generally paid but
                                            in no event later than March 15<SUP>th</SUP> of the calendar year after the calendar year
                                            in which the Executive&rsquo;s termination occurs. Upon the Executive&rsquo;s death, stock
                                            options previously granted to the Executive that are vested and fully exercisable at the
                                            time of death shall remain fully exercisable, by the Executive&rsquo;s legal representatives,
                                            through their respective original maximum terms (subject to earlier termination in connection
                                            with a change in control of the Company and similar events as provided in the applicable
                                            plan and/or award agreement) and otherwise in accordance with their respective terms and
                                            conditions. All stock options and stock awards (and similar equity rights) that have not
                                            vested prior the date of death shall be forfeited.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Executive shall become physically or mentally disabled so that the Executive is unable substantially
                                            to perform her services, even with a reasonable accommodation required by law, hereunder
                                            for (1) a period of one-hundred twenty (120) consecutive days, or (2) shorter periods aggregating
                                            one-hundred eighty (180) days during any twelve (12) month period; <I>provided, however</I>,
                                            that the Company may terminate the Executive&rsquo;s employment under this Section 6(b) only
                                            upon thirty (30) days&rsquo; prior written notice given by the Board to the Executive. Notwithstanding
                                            such disability the Company shall continue to pay the Executive her Base Salary through the
                                            date of such termination. In addition, the Executive shall be entitled to a pro rata annual
                                            performance bonus (prorated by multiplying the full year bonus that otherwise would be due
                                            by the percentage derived from dividing the number of days in the then-current year prior
                                            to the termination on account of disability of the Executive by three-hundred sixty-five
                                            (365)) with respect to the fiscal year of the Company during which such termination occurs.
                                            Such pro rata bonus shall be paid at the same time as such annual performance bonuses are
                                            generally paid but in no event later than March 15<SUP>th</SUP> of the calendar year after
                                            the calendar year in which the Executive&rsquo;s termination occurs. Upon such a disability,
                                            stock options previously granted to the Executive that are vested and fully exercisable at
                                            the time of disability shall remain fully exercisable, by the Executive or her legal representatives,
                                            should she have such, through their respective original maximum terms (subject to earlier
                                            termination in connection with a change in control of the Company and similar events as provided
                                            in the applicable plan and/or award agreement) and otherwise in accordance with their respective
                                            terms and conditions. All stock options and stock awards (and similar equity rights) that
                                            have not vested prior to the date of disability shall be forfeited by the Executive.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Executive acts, or fails to act, in a manner that provides Cause for termination. For purposes
                                            of this Agreement, the term &ldquo;Cause&rdquo; means (1) the Executive&rsquo;s indictment
                                            for, or conviction of, any crime or serious offense involving money or other property that
                                            constitutes a felony in the jurisdiction involved; (2) the Executive&rsquo;s willful and
                                            ongoing neglect of, or failure to discharge, duties (including fiduciary duties), responsibilities
                                            and obligations with respect to the Company hereunder, <I>provided</I> such neglect or failure
                                            remains uncured for a period of thirty (30) days after written notice describing the same
                                            is given to the Executive by the Board; (3) the Executive&rsquo;s violation of any of the
                                            non-competition provisions of Section 5 hereof or the Executive&rsquo;s material breach of
                                            any provisions of Section 12 hereof or Exhibit B hereto, or (4) any act of fraud or embezzlement
                                            by the Executive involving the Company or any of its Affiliates. All determinations of Cause
                                            for termination pursuant to this Section 6 (including a determination, if applicable, of
                                            whether Cause has been cured) shall be made by the Board, and shall require at least a two-thirds
                                            (2/3) vote of the entire Board excluding the Executive, should she then be a member of the
                                            Board.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company terminates this Agreement and the Executive&rsquo;s employment for any reason other
                                            than for death, disability, or Cause</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Termination
                                            by the Executive</U>.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Good
                                            Reason</U>. The Executive may terminate this Agreement and the Executive&rsquo;s employment
                                            hereunder for Good Reason. For purposes of this Agreement, &ldquo;Good Reason&rdquo; means
                                            the occurrence, without the Executive&rsquo;s written consent, of any of the following events:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            material adverse change in the Executive&rsquo;s authority, duties or responsibilities, or
                                            titles;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            material reduction in the Executive&rsquo;s Base Salary or target annual performance bonus
                                            opportunity;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            material breach by the Company of its obligations under this Agreement; or</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            failure of the Company to obtain the assumption in writing of its obligation to perform this
                                            Agreement by any successor to all or substantially all of the assets of the Company;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>provided</I>,
that the Executive&rsquo;s termination shall only constitute a termination for Good Reason if (x) the Executive provides the Company
with written notice detailing the specific condition alleged to constitute Good Reason within ninety (90) days after the initial occurrence
of such condition, (y) the Company fails to cure such condition within thirty (30) days after the Company&rsquo;s receipt of such notice,
and (z) the date of the Executive&rsquo;s termination of employment occurs within thirty (30) days following the expiration of the Company&rsquo;s
cure period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Without
                                            Good Reason</U>. The Executive may terminate this Agreement and the Executive&rsquo;s employment
                                            hereunder without Good Reason at any time by providing thirty (30) days&rsquo; advance written
                                            notice to the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Severance
                                            and Benefit Continuation</U>.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Termination
                                            by the Company for Cause or Termination by the Executive Without Good Reason</I>. If the
                                            Company terminates this Agreement and the Executive&rsquo;s employment for Cause pursuant
                                            to Section 6(c) hereof, or if the Executive terminates employment without Good Reason pursuant
                                            to Section 7(b), no severance or benefit continuation provisions shall apply; <I>provided,
                                            however</I>, that the Executive shall have the same opportunity to continue group health
                                            benefits at the Executive&rsquo;s expense in accordance with the Consolidated Omnibus Budget
                                            Reconciliation Act of 1985 (&ldquo;COBRA&rdquo;) as is available generally to other employees
                                            terminating employment with the Company. All stock options and stock awards (and similar
                                            equity rights) held by the Executive that have vested prior to such termination of this Agreement
                                            may be exercised by the Executive for a period of one hundred eighty (180) days after the
                                            date of termination (subject to earlier termination in connection with a change in control
                                            of the Company and similar events as provided in the applicable plan and/or award agreement),
                                            at which time they shall automatically be forfeited if not exercised. All stock options and
                                            stock awards (and similar equity rights) that have not vested prior to such termination shall
                                            be forfeited by the Executive.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Termination
                                            for Death or Disability.</I> In the event of termination of this Agreement pursuant to Section
                                            6(a) or 6(b) by reason of the death or disability of the Executive, in addition to the Base
                                            Salary payments and pro rata annual performance bonus provided for in paragraph (a) or (b)
                                            of Section 6, as applicable, the Company shall continue to provide all benefits subject to
                                            COBRA, at its sole cost and expense, with respect to the Executive and her dependents for
                                            the maximum period provided by COBRA.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Termination
                                            by the Company Other Than for Death, Disability, or Cause or Termination by the Executive
                                            for Good Reason Outside of the Change in Control Protection Period</I>. If (1) the Company
                                            terminates this Agreement and the Executive&rsquo;s employment other than for Cause pursuant
                                            to Section 6(d) or (2) the Executive terminates this Agreement and her employment for Good
                                            Reason pursuant to Section 7(a), and, in either case, such termination does not occur during
                                            the Change in Control Protection Period (as defined in Section 8(d)), then, subject to Section
                                            8(e):</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Company shall pay the Executive in accordance with its normal payroll practice an amount
                                            equal to the Executive&rsquo;s Base Salary at the annualized rate in effect on the date of
                                            such termination), such payment to be made in equal monthly installments (rounded down to
                                            the nearest whole cent) over a period of twelve (12) consecutive months following the Executive&rsquo;s
                                            Separation from Service (as defined in Section 11) (the &ldquo;Severance Period&rdquo;),
                                            with the first installment payable, subject to Section 8(e) and Section 13, in the month
                                            following the month in which the Executive&rsquo;s Separation from Service occurs;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            Company employee benefit plans and programs (including, but not limited to, the plans and
                                            programs set forth in Section 3(e)), other than participation in any Company tax-qualified
                                            retirement plan and any bonus, equity or other incentive plans and programs, applicable to
                                            the Executive shall be continued for the Severance Period, with the Company continuing to
                                            pay the same portion of the cost of such benefits as the Company would pay if the Executive
                                            were still actively employed (or, if such benefits are not available, or cannot be provided
                                            due to applicable law, the Company shall instead pay the Executive a cash amount equal to
                                            the after-tax economic equivalent thereof, which amount shall be paid in monthly installments
                                            at the same time and in the same manner as the Base Salary continuation payments; provided
                                            that, with respect to any benefit to be provided on an insured basis, such cash value shall
                                            be the value of the premiums expected to be paid for such coverage for such month, and with
                                            respect to other benefits, such value shall be the value of the expected cost to the Company
                                            of providing such benefits for such month). Notwithstanding the foregoing, with respect to
                                            group health plan coverage, (A) the Company&rsquo;s obligations under this Section shall
                                            be subject to the Executive timely electing COBRA coverage; (B) such obligations shall not
                                            extend beyond the maximum length of time the Executive is entitled to such COBRA coverage;
                                            and (C) if the Executive becomes re-employed with another employer during the Severance Period
                                            and is eligible to receive comparable group health insurance coverage under another employer&rsquo;s
                                            plans, the Company&rsquo;s obligations under this Section shall be reduced to the extent
                                            comparable coverage is actually provided to the Executive and her dependents, and any such
                                            coverage shall be promptly reported by the Executive to the Company; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            stock options and awards of restricted stock (and similar equity rights), to the extent outstanding
                                            and vested on the date of such termination of this Agreement, shall remain fully exercisable
                                            through their respective original maximum terms (subject to earlier termination in connection
                                            with a change in control of the Company and similar events as provided in the applicable
                                            plan and/or award agreement) and otherwise in accordance with their respective terms and
                                            conditions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Termination
                                            by the Company Other Than for Death, Disability, or Cause or Termination by the Executive
                                            Based for Good Reason During the Change in Control Protection Period</I>. If, during the
                                            period commencing on the date four (4) months prior to a Change in Control and ending on
                                            the one (1) year anniversary of such Change in Control (the &ldquo;Change in Control Protection
                                            Period&rdquo;), (1) the Company terminates this Agreement and the Executive&rsquo;s employment
                                            other than for Cause pursuant to Section 6(d) or (2) the Executive terminates this Agreement
                                            and her employment for Good Reason pursuant to Section 7(a), then, subject to Section 8(e):</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Company shall pay the Executive in accordance with its normal payroll practice an amount
                                            equal to two (2) times Executive&rsquo;s Base Salary at the annualized rate in effect on
                                            the date of such termination such payment to be made in equal monthly installments (rounded
                                            down to the nearest whole cent) over a period of twelve (12) consecutive months following
                                            the Executive&rsquo;s Separation from Service (as defined in Section 12) (the &ldquo;CIC
                                            Severance Period&rdquo;), with the first installment payable, subject to Section 8(e) and
                                            Section 15, in the month following the month in which the Executive&rsquo;s Separation from
                                            Service occurs;</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            Company employee benefit plans and programs (including, but not limited to, the plans and
                                            programs set forth in Section 3(e)), other than participation in any Company tax-qualified
                                            retirement plan, applicable to the Executive shall be continued for the CIC Severance Period
                                            (or, if such benefits are not available, or cannot be provided due to applicable law, the
                                            Company shall instead pay the Executive a cash amount equal to the after-tax economic equivalent
                                            thereof, which amount shall be paid in monthly installments at the same time and in the same
                                            manner as the Base Salary continuation payments; provided that, with respect to any benefit
                                            to be provided on an insured basis, such cash value shall be the value of the premiums expected
                                            to be paid for such coverage for such month, and with respect to other benefits, such value
                                            shall be the value of the expected cost to the Company of providing such benefits for such
                                            month). Notwithstanding the foregoing, with respect to group health plan coverage, (A) the
                                            Company&rsquo;s obligations under this Section shall be subject to the Executive timely electing
                                            COBRA coverage; (B) such obligations shall not extend beyond the maximum length of time the
                                            Executive is entitled to such COBRA coverage; and (C) if the Executive becomes re-employed
                                            with another employer during the Severance Period and is eligible to receive comparable group
                                            health insurance coverage under another employer&rsquo;s plans, the Company&rsquo;s obligations
                                            under this Section shall be reduced to the extent comparable coverage is actually provided
                                            to the Executive and her dependents, and any such coverage shall be promptly reported by
                                            the Executive to the Company; and</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            stock options and awards of restricted stock (and similar equity rights), to the extent outstanding
                                            and vested on the date of such termination of this Agreement), shall remain fully exercisable
                                            through their respective original maximum terms (subject to earlier termination in connection
                                            with a change in control of the Company and similar events as provided in the applicable
                                            plan and/or award agreement) and otherwise in accordance with their respective terms and
                                            conditions; <I>provided, however</I>, that the award agreements evidencing the First Option
                                            and the Second Option shall provide that the portions thereof that remain unvested immediately
                                            prior to the consummation of a change in control of the Company will accelerate and vest
                                            in full in connection with such change in control.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            a condition of receiving (i) the payments provided for in Section 8(c) or 8(d), as applicable,
                                            or, if applicable, (ii) the pro rata bonus provided for in Section 6(b), the Executive or
                                            her legal representatives, should she have such, shall first execute and deliver to the Company
                                            within twenty-one (21) days (or such other period required under applicable law) following
                                            such termination of employment a general release of all claims against the Company, its Affiliates,
                                            agents and employees (other than any claims or rights pursuant to the Agreement or pursuant
                                            to equity or employee benefit plans that cannot be released by law), in a form acceptable
                                            to the Company, and shall not revoke such release within any revocation period provided under
                                            applicable law. Notwithstanding the foregoing provisions of this Section 8(e), no release
                                            to be granted by the Executive shall be required to cause the Executive to release the Company
                                            from, waive, or forego in any way any of the Executive&rsquo;s rights to indemnification
                                            under the applicable provisions of the Certificate of Incorporation or Bylaws of the Company,
                                            or any then-existing agreement between the Company and the Executive with respect thereto,
                                            or any vested rights or benefits applicable to Executive. Further, the Company acknowledges
                                            and agrees that the release will not include any confidentiality or non-competition, non-solicitation
                                            and non-disparagement covenants binding on the Executive that exceed the scope and/or duration
                                            of those covenants set forth in Sections 3(g) and 5, respectively, hereof.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Nonrenewal</I>.
                                            For purposes of this Agreement, an election by the Company not to renew this Agreement beyond
                                            the end of the then-current Term shall be considered a termination of this Agreement Other
                                            Than for Cause, and an election by the Executive not to renew this Agreement beyond the end
                                            of the then-current Term shall be considered a termination of this Agreement Without Good
                                            Reason.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cooperation</U>.
                                            Following the termination of the Executive&rsquo;s employment, the Executive agrees to cooperate
                                            with, and assist, the Company to ensure a smooth transition in management and, if requested
                                            by the Company, to make herself available to consult during regular business hours at mutually
                                            agreed upon times for up to a three (3) month period thereafter. At any time following the
                                            termination of her employment, the Executive will provide such information as the Company
                                            may request with respect to any Company-related transaction or other matter in which the
                                            Executive was involved in any way, or of which the Executive had knowledge, while employed
                                            by the Company. The Executive further agrees, during the Employment Period and thereafter,
                                            to assist and cooperate with the Company in connection with the defense or prosecution of
                                            any claim that may be made against, or by, the Company or its Affiliates, in connection with
                                            any dispute or claim of any kind involving the Company or its Affiliates, including providing
                                            testimony in any proceeding before any arbitral, administrative, judicial, legislative or
                                            other body or agency. The Executive shall be entitled to reimbursement for all properly documented
                                            expenses reasonably incurred in connection with rendering transition services under this
                                            Section, including, but not limited to, reimbursement for all reasonable travel, lodging,
                                            meal expenses and legal fees, and the Executive shall be entitled to a per diem amount for
                                            her services equal to her then most recent annualized Base Salary under this Agreement, divided
                                            by two-hundred forty (240) (<I>i.e.</I>, business days in the calendar year). Any amounts
                                            that become due under this Section shall be paid no later than March 15<SUP>th</SUP> of the
                                            calendar year after the calendar year in which the expense is incurred or the services rendered.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
                                            Mitigation</U>. The Executive shall not be required to mitigate the amount of any payment
                                            provided for hereunder by seeking other employment or otherwise, nor shall the amount of
                                            any payment provided for hereunder be reduced by any compensation earned by the Executive
                                            as the result of employment by another employer after the date of termination of employment
                                            by the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Definitions</U>.
                                            As used herein, the following terms have the following meeting:</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Affiliate&rdquo;
                                            means, with respect to any Person, any other Person, controlled by or under common control
                                            with the Person in question, determined in accordance with Rule 12b-2 under the Exchange
                                            Act.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: justify; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Change
                                            in Control&rdquo; means the occurrence of any of the following events:</FONT></P>
                                                                                <P STYLE="margin: 0pt"></P></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
                                            in Ownership of the Company. A change in the ownership of the Company which occurs on the
                                            date that any one Person, or more than one Person acting as a group, acquires ownership of
                                            the stock of the Company that, together with the stock held by such Person, constitutes more
                                            than 50% of the total voting power of the stock of the Company, except that any change in
                                            the ownership of the stock of the Company as a result of a private financing of the Company
                                            that is approved by the Board will not be considered a Change in Control; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
                                            in Effective Control of the Company. A change in the effective control of the Company which
                                            occurs on the date that a majority of members of the Board is replaced during any twelve
                                            (12) month period by directors whose appointment or election is not endorsed by two-thirds
                                            (2/3) of the members of the Board prior to the date of the appointment or election. For purposes
                                            of this clause (ii), if any Person is considered to be in effective control of the Company,
                                            the acquisition of additional control of the Company by the same Person will not be considered
                                            a Change in Control; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
                                            in Ownership of a Substantial Portion of the Company&rsquo;s Assets. A change in the ownership
                                            of a substantial portion of the Company&rsquo;s assets which occurs on the date that any
                                            Person acquires (or has acquired during the twelve (12) month period ending on the date of
                                            the most recent acquisition by such Person or Persons) assets from the Company that have
                                            a total gross fair market value of more than 50% of the total gross fair market value of
                                            all of the assets of the Company immediately prior to such acquisition or acquisitions. For
                                            purposes of this subsection (iii), gross fair market value means the value of the assets
                                            of the Company, or the value of the assets being disposed of, determined without regard to
                                            any liabilities associated with such assets.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Section 11(b), Persons will be considered to be acting as a group if they are owners of a corporation that enters into
a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, a transaction shall not constitute a &ldquo;Change in Control&rdquo; unless it is a &ldquo;change in the ownership or
effective control&rdquo; of the Company, or a change &ldquo;in the ownership of a substantial portion of the assets&rdquo; of the Company
within the meaning of Section 409A of the U.S. Internal Revenue Code of 1986, as amended (&ldquo;Code Section 409A&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
and for the avoidance of doubt, a transaction will not constitute a Change in Control if: (A) its sole purpose is to change the jurisdiction
of the Company&rsquo;s incorporation, or (B) its sole purpose is to create a holding company that will be owned in substantially the
same proportions by the Persons who held the Company&rsquo;s securities immediately before such transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Company&rsquo;s
                                            Field of Interest&rdquo; means the primary businesses of the Company as of the Executive&rsquo;s
                                            termination, as described in the Company&rsquo;s then two most recent Annual Reports on Form
                                            10-K filed by the Company with the Securities and Exchange Commission (subject to any further
                                            description of such businesses that may be included in any Quarterly Reports on Form 10-Q
                                            or Current Reports on Form 8-K thereafter filed by the Company with the Securities and Exchange
                                            Commission) or as determined from time to time by the Board during the Employment Period.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Exchange
                                            Act&rdquo; shall mean the Securities Exchange Act of 1934, as amended.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Person&rdquo;
                                            shall mean a natural person, corporation, or other entity, including such meaning as used
                                            in Sections 13(d) and 14(d) of the Exchange Act.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            used herein, a &ldquo;Separation from Service&rdquo; occurs when the Executive dies, retires,
                                            or otherwise has a termination of employment with the Company that constitutes a &ldquo;separation
                                            from service&rdquo; within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without
                                            regard to the optional alternative definitions available thereunder.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Representations
                                            by Executive</U>. The Executive represents and warrants that she has full right, power and
                                            authority to execute this Agreement and perform her obligations hereunder and that this Agreement
                                            has been duly executed by the Executive and such execution and the performance of this Agreement
                                            by the Executive do not and will not result in any conflict, breach or violation of or default
                                            under any other agreement or any judgment, order or decree to which the Executive is a party
                                            or by which she is bound. The Executive acknowledges and agrees that any material breach
                                            of the representations set forth in this Section 12 will constitute Cause under Section 6.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
                                            409A Compliance</U>.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            is intended that any amounts payable under this Agreement shall either be exempt from or
                                            comply with Code Section 409A (including the Treasury regulations and other published guidance
                                            relating thereto) so as not to subject the Executive to payment of any additional tax, penalty
                                            or interest imposed under Code Section 409A. Notwithstanding the foregoing, nothing in this
                                            Agreement shall be interpreted or construed to transfer any liability for any tax (including
                                            a tax or penalty due as a result of a failure to comply with Code Section 409A) from the
                                            Executive to the Company or to any other individual or entity. The provisions of this Agreement
                                            shall be construed and interpreted to avoid the imputation of any such additional tax, penalty
                                            or interest under Code Section 409A yet preserve (to the nearest extent reasonably possible)
                                            the intended benefit payable to the Executive. Each installment payment required under this
                                            Agreement shall be considered a separate payment for purposes of Code Section 409A.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Executive is a &ldquo;specified employee&rdquo; within the meaning of Treasury Regulation
                                            Section 1.409A-1(i) as of the date of the Executive&rsquo;s Separation from Service, then
                                            the payment of any amount due under this Agreement (i) that is deferred compensation subject
                                            to Section 409A and (ii) for which the payment event is a Separation from Service, shall
                                            be delayed until the earlier of (x) the date which is six (6) months after her Separation
                                            from Service for any reason other than death, or (y) the date of the Executive&rsquo;s death.
                                            The provisions of this Section 13(b) shall only apply if, and to the extent, required to
                                            avoid the imputation of any tax, penalty or interest pursuant to Code Section 409A. Any amounts
                                            otherwise payable to the Executive upon or in the six (6) month period following the Executive&rsquo;s
                                            Separation from Service that are not so paid by reason of this Section 13(b) shall be paid
                                            (without interest) as soon as practicable (and in all events within thirty (30) days) after
                                            the date that is six (6) months after the Executive&rsquo;s Separation from Service (or,
                                            if earlier, as soon as practicable, and in all events within thirty (30) days, after the
                                            date of the Executive&rsquo;s death).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            the extent that any benefits pursuant to Section 8(c)(ii) or 8(d)(ii) or reimbursements pursuant
                                            to Section 3(d) or 3(e) are taxable to the Executive, any reimbursement payment due to the
                                            Executive pursuant to any such provision shall be paid to the Executive on or before the
                                            last day of the Executive&rsquo;s taxable year following the taxable year in which the related
                                            expense was incurred. The benefits and reimbursements pursuant to such provisions are not
                                            subject to liquidation or exchange for another benefit and the amount of such benefits and
                                            reimbursements that the Executive receives in one taxable year shall not affect the amount
                                            of such benefits or reimbursements that the Executive receives in any other taxable year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Arbitration</U>.
                                            The parties shall attempt in good faith to resolve all claims, disputes and other disagreements
                                            arising hereunder by negotiation. In the event that a dispute between the parties cannot
                                            be resolved within thirty (30) days of written notice from one party to the other party,
                                            such dispute shall, at the request of either party, after providing written notice to the
                                            other party, be submitted to arbitration in Lawrenceville, New Jersey in accordance with
                                            the arbitration rules of the American Arbitration Association then in effect. The notice
                                            of arbitration shall specifically describe the claims, disputes or other matters in issue
                                            to be submitted to arbitration. The parties shall jointly select a single arbitrator who
                                            shall have the authority to hold hearings and to render a decision in accordance with the
                                            arbitration rules of the American Arbitration Association. If the parties are unable to agree
                                            within ten (10) days, the arbitrator shall be selected by the Chief Judge (or equivalent)
                                            of the Superior Court for Mercer County, New Jersey, or by such other adjudicator within
                                            the New Jersey court system as the parties may agree. The discovery rights and procedures
                                            provided by the Federal Rules of Civil Procedure shall be available and enforceable in the
                                            arbitration proceeding. The written decision of the arbitrator so appointed shall be conclusive
                                            and binding on the parties and enforceable by a court of competent jurisdiction. The expenses
                                            of the arbitration shall be borne equally by the parties to the arbitration, and each party
                                            shall pay for and bear the cost of its or her own experts, evidence and legal counsel, unless
                                            the arbitrator rules otherwise in the arbitration. Each party agrees to use its or her best
                                            efforts to cause a final decision to be rendered with respect to the matter submitted to
                                            arbitration within one hundred twenty(120) days after its submission. Notwithstanding the
                                            foregoing, the Company shall be free to pursue its rights and remedies under Section 5 hereof
                                            and pursuant to Exhibit B hereto in any court of competent jurisdiction, without regard to
                                            the arbitral proceedings contemplated by this Section 14.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notices</U>.
                                            All notices, requests, consents and other communications required or permitted to be given
                                            hereunder or contemplated or in connection herewith shall be in writing and shall be deemed
                                            to have been duly given if sent by private overnight mail service (delivery deemed to have
                                            occurred on the confirmed date of delivery by such service), registered or certified mail
                                            (return receipt to be requested and delivery deemed to have occurred when received by the
                                            recipient), or electronic mail (delivery deemed to occur upon written confirmation of receipt),
                                            or if delivered personally, as follows (or to such other address as either party shall designate
                                            by notice in writing to the other in accordance herewith):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">997
Lenox Drive, Suite 100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
NJ 08648</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Chairman of the Compensation Committee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
609-896-9100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
609-896-2200</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Executive:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
Lindborg, PhD</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:
1970 Massachusetts Ave, Lexington, MA 02421</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>stacyrlindborg@gmail.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
to such other most recent contact information as the Company has in its records.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Indemnification
                                            and Limitation of Liability</U>. The Corporation acknowledges and agrees that the protections
                                            afforded by Article Eighth of the Amended and Restated Certificate of Incorporation, as amended,
                                            of the Corporation, and Article VI of the Bylaws are available to the Executive throughout
                                            the Employment Period and thereafter, in accordance with their respective terms.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Recoupment</U>.
                                            Notwithstanding anything in this Agreement to the contrary, any payments or benefits paid
                                            or due to the Executive hereunder shall be subject to any recoupment or clawback policy adopted
                                            by the Company from time to time. The Company&rsquo;s rights under this Section 17 shall
                                            be full recourse and shall be in addition to its other rights under this Agreement. The Company
                                            shall have the right to offset the Executive&rsquo;s obligations under this Section 17 against
                                            any amounts otherwise owed to the Executive from the Company, to the extent permitted by
                                            applicable law.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>General</U>.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement shall be governed by and construed and enforced in accordance with the laws of
                                            the State of New Jersey applicable to agreements made and to be performed entirely in New
                                            Jersey without regard to any conflicts-of-law provisions thereof. To the extent any dispute
                                            (including an action by the Company to enforce its rights and remedies pursuant to Section
                                            5) is not subject to arbitration as set forth in Section 14, the parties agree that any such
                                            action will be brought in a state or federal court in the State of New Jersey having competent
                                            jurisdiction.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement, together with the PIIA and the Stock Plan and stock option agreements described
                                            in Section 3(c), sets forth the entire agreement and understanding of the parties relating
                                            to the subject matter hereof, and supersedes all prior agreements, arrangements and understandings,
                                            written or oral, relating to the subject matter hereof, including without limitation the
                                            offer letter dated March 8, 2024. No representation, promise or inducement has been made
                                            by either party that is not embodied in this Agreement, and neither party shall be bound
                                            by or liable for any alleged representation, promise or inducement not so set forth. The
                                            Company hereby informs Executive that she has the right to consult with counsel prior to
                                            executing this Agreement, and Executive acknowledges that she has had the opportunity to
                                            do so. Notwithstanding the foregoing, in the event that the provisions hereof shall conflict
                                            with the terms of any stock option grant agreement, stock award agreement or similar document
                                            granting stock options, warrants or similar rights, then the terms hereof shall control.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement may be amended, modified, superseded, canceled, renewed or extended, and the terms
                                            or covenants hereof may be waived, only by a written instrument executed by the parties hereto,
                                            or in the case of a waiver, by the party waiving compliance. The failure of a party at any
                                            time or times to require performance of any provision hereof shall in no manner affect the
                                            right at a later time to enforce the same. No waiver by a party of the breach of any term
                                            or covenant contained in this Agreement, whether by conduct or otherwise, or any one or more
                                            or continuing waivers of any such breach, shall constitute a waiver of the breach of any
                                            other term or covenant contained in this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement shall be binding upon and inure to the benefit of the legal representatives, heirs,
                                            distributees, successors and permitted assigns of the parties hereto. The Company may not
                                            assign its rights and obligation under this Agreement without the prior written consent of
                                            the Executive, except to a successor to substantially all the Company&rsquo;s business that
                                            expressly assumes the Company&rsquo;s obligations hereunder in writing. For purposes of this
                                            Agreement, &ldquo;successors&rdquo; shall mean any successor by way of share exchange, merger,
                                            consolidation, reorganization or similar transaction, or the sale of all or substantially
                                            all of the assets of the Company. The Executive may not assign, transfer, alienate or encumber
                                            any rights or obligations under this Agreement, except by will or operation of law, <I>provided
                                            </I>that the Executive may designate beneficiaries to receive any payments permitted under
                                            the terms of the Company&rsquo;s benefit plans.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement, and all obligations of the Company and the Executive hereunder, shall terminate
                                            upon the termination of the Executive&rsquo;s employment, with the following exceptions:
                                            (i) the Executive&rsquo;s continuing obligations under Sections 5 and 9; (ii) the benefits
                                            to be paid by the Company in accordance with Section 8 and the mitigation provisions of Section
                                            10; (iii) the Executive&rsquo;s rights to indemnification under Section 16; and (iv) and
                                            the relevant provisions in Sections 13 through 18. In addition, the PIIA shall survive the
                                            termination of this Agreement and continue in accordance with its terms.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page follows.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> of 16</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, each of the parties has executed this Agreement as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Imunon,
    Inc.</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Michael H. Tardugno </FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print
    Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    H. Tardugno</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
                                            Stacy Lindborg</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print
    Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    Lindborg, Ph.D.</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attachments:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
A &ndash; Permitted Activities</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
B &ndash; Employee Proprietary Information and Inventions Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
Page to Employment Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 28.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 28.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Permitted
Activities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 28.5pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Service
                                            on the Board of Directors of Brainstorm Cell Therapeutics</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 28.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 28.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employee
Proprietary Information and Inventions Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 28.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="ex99-1_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON
Appoints Director Dr. Stacy R. Lindborg as President and CEO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Assumes
leadership role as Company anticipates multiple near-term clinical milestones</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Brings
extensive leadership and experience in drug development and business strategy</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAWRENCEVILLE,
N.J. (May 8, 2024) &ndash; IMUNON, Inc. (NASDAQ: IMNN</B>), a clinical-stage drug-development company focused on developing non-viral
DNA-mediated immunotherapy and next-generation vaccines, today announced the appointment of Stacy R. Lindborg, Ph.D. as President and
Chief Executive Officer, effective May 13, 2024. Dr. Lindborg has served on IMUNON&rsquo;s board of directors since 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Lindborg assumes the leadership of IMUNON at a pivotal time. Topline results from the Phase 2 OVATION 2 Study with IMUNON&rsquo;s lead
asset, IMNN-001 using the TheraPlas modality, in advanced ovarian cancer are expected by mid-summer. Phase 1 proof-of-concept data from
IMNN-101 using the PlaCCine modality in seasonal COVID-19 are anticipated by year-end.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Dr.
Lindborg is uniquely qualified to take the reins as IMUNON&rsquo;s President and CEO, bringing a track record of success in virtually
every aspect of the work before the company,&rdquo; said Michael H. Tardugno, IMUNON&rsquo;s executive chairman. &ldquo;Her ability to
navigate global regulatory paths, having successfully delivered products from the clinic to the market, will be valuable to IMUNON as
our pipeline advances. We have benefited significantly from her counsel as a director, where she has played an integral role in establishing
our strategic priorities. We now look forward to benefiting from her expertise in a new and deeper capacity, especially as our near-term
data readouts will require important decisions with respect to advancing various programs and assets.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Lindborg has nearly 30 years of pharmaceutical and biotech industry experience with a particular focus on R&amp;D, regulatory affairs,
executive management and strategy development. She has designed, hired and led global teams, guiding long-term vision for growth through
analytics and stimulating innovative development platforms to increase productivity. She joins IMUNON from BrainStorm Cell Therapeutics,
where she was Executive Vice President and Co-Chief Executive Officer and where she remains a member of the board of directors. At BrainStorm
she was accountable for creating and executing clinical development strategies through registration and launch and progressed its novel
cell therapy for ALS through a positive Phase 3 Special Protocol Assessment (SPA) study with the U.S. Food and Drug Administration. She
interacted frequently with investors and analysts, represented the company in the scientific community as well as with the media, and
played an active role in discussions with potential business partners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Lindborg previously was Vice President &amp; Global Analytics and Data Sciences Head, responsible for R&amp;D and marketed products at
Biogen. She began her biopharmaceutical career at Eli Lilly and Company where over the course of 16 years she assumed positions of increasing
responsibility, including Head of R&amp;D strategy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commenting
on her appointment, Dr. Lindborg said, &ldquo;I have enjoyed being close to the emerging science during the development of our IL-12
therapy TheraPlas and our PlaCCine modalities, in addition to getting to know the depth of talent in the company. I am thrilled to assume
direct managerial responsibilities as we work to bring these important products and technologies to patients. I am also excited by the
prospect of creating shareholder value as we determine the next steps for our platform products.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Lindborg received an M.A. and Ph.D. in statistics, and a B.A. in psychology and math from Baylor University. She has authored more than
200 presentations and 90 manuscripts that have been published in peer-reviewed journals, including 20 first-authored. She has held numerous
positions within the International Biometric Society and American Statistical Association and was elected Fellow in 2008.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
IMUNON</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IMUNON
is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body&rsquo;s natural
mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach
from conventional therapies. IMUNON is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas<SUP>&reg;</SUP>,
is developed for the coding of cytokines and other therapeutic proteins in the treatment of solid tumors where an immunological approach
is deemed promising. The second modality, PlaCCine<SUP>&reg;</SUP>, is developed for the delivery of DNA-coded viral antigens that can
elicit a strong immunological response. This technology may represent a promising platform for the development of vaccines in infectious
diseases. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer
currently in Phase 2 development. IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting
molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally, the Company is entering a first-in-human study
of its COVID-19 booster vaccine (IMNN-101). We will continue to leverage these modalities and to advance the technological frontier of
plasmid DNA to better serve patients with difficult-to-treat conditions. For more information on IMUNON, visit <U>www.imunon.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>IMUNON
wishes to inform readers that forward-looking statements in this news release are made pursuant to the &ldquo;safe harbor&rdquo; provisions
of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including, but not
limited to, statements regarding the Company&rsquo;s IND application, expectations regarding the Phase 1 clinical study of IMNN-101,
including with respect to enrollment for the study and reporting of data, the potential efficacy and safety profile of our PlaCCine platform,
potential partnering opportunities, and the Company&rsquo;s plans and expectations with respect to its development programs more generally,
are forward-looking statements. We generally identify forward-looking statements by using words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo;
&ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;intend&rdquo; and similar expressions
(as well as other words or expressions referencing future events, conditions or circumstances). Readers are cautioned that such forward-looking
statements involve risks and uncertainties including, without limitation, uncertainties relating to unforeseen changes in the course
of research and development activities and in clinical trials; the uncertainties of and difficulties in analyzing interim clinical data;
the significant expense, time and risk of failure of conducting clinical trials; the need for IMUNON to evaluate its future development
plans; possible actions by customers, suppliers, competitors or regulatory authorities; and other risks detailed from time to time in
IMUNON&rsquo;s filings with the Securities and Exchange Commission. IMUNON assumes no obligation, except to the extent required by law,
to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-color: black; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000"><B>Contacts:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-color: black; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-color: black; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000"><B>IMUNON</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000"><B>LHA
    Investor Relations</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000">Jeffrey
    W. Church</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000">Kim
    Sutton Golodetz</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000">609-482-2455</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000">212-838-3777</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000"><U>jchurch@imunon.com</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000">kgolodetz@lhai.com</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">#
# #</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Z +H# 2(  A$! Q$!_\0
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M::6464_%NMW?Q!\1'3=+8C3+-7DWG[I"CYI&]NP^OO5[X)V>[4M5O,'$<21
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..V]%%3.;G)R?43=W<_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>imnn-20240503.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWa+AKbP9z5Z8SekhvWB/bZkqHyQq/+r/Cy/iSuSGgd8L -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:IMNN="http://imunon.com/20240503" elementFormDefault="qualified" targetNamespace="http://imunon.com/20240503">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://imunon.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="imnn-20240503_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="imnn-20240503_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>imnn-20240503_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>imnn-20240503_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://imunon.com/role/Cover" xlink:href="imnn-20240503.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140678429874800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 03, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  03,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IMUNON,
INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000749647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-1256615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">997
    Lenox Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lawrenceville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08648-2311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(609)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">896-9100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value
    $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IMNN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( /I!J%@'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #Z0:A8?$3W./     K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M3L,P#(=?!>7>.NTV0%'7"]-.("$Q"<0M2KPMHOFCQ*C=VY.6K1."!^ 8^Y?/
MGR4W*@CE(SY''S"2P70SV,XEH<*:'8F" $CJB%:F,B=<;NY]M)+R,QX@2/4A
M#P@UY[=@D:26)&$$%F$FLK;12JB(DGP\X[6:\>$S=A-,*\ .+3I*4)45L':<
M&$Y#U\ 5,,((HTW?!=0S<:K^B9TZP,[)(9DYU?=]V2^F7-ZA@K>GQY=IW<*X
M1-(IS+^2$70*N&:7R:^+A\UNR]J:U\N"KPI^OZMJ4:W$\NY]=/WA=Q6V7IN]
M^<?&%\&V@5]WT7X!4$L#!!0    ( /I!J%B97)PC$ 8  )PG   3    >&PO
M=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$
M[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4
M\GA@V2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4
MR]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C
M 1-702:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6
M:\?1TDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+
MTHMP' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3
M:W?=TXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@
M %AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ W
MQ-%,4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYK
ME']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;V
MD:4E,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?
MR"VZY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:
M/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#Q
MK9P\'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-
MZ#,:P4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB
M&38:<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.
MBY 1OQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR
M- >CFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"
MP#E_+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,I
MV#F?P.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4W
MBA*>0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F
M.$KTL<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1
MN0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/
MPT.'>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,K
MD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;
M\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\
MX^;'<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;Z
MEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10
M[I*0!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%
M(1=RX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^
M)F!+PWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#
M7N83+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1
M/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO
M0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #Z0:A8JL0B%C,!   B @
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M-_=%KLWC":[?#'!X=/X!4$L#!!0    ( /I!J%AED'F2&0$  ,\#   3
M6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/
M&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB
M>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9
M/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1
MB5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9
M_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^D<WC_0QI-^2!
M8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ ^D&H
M6 =!36*!    L0   !               ( !     &1O8U!R;W!S+V%P<"YX
M;6Q02P$"% ,4    " #Z0:A8?$3W./     K @  $0              @ &O
M    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #Z0:A8F5R<(Q &  "<
M)P  $P              @ '. 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4
M Q0    ( /I!J%@]:/*&8@0  ",1   8              " @0\(  !X;"]W
M;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #Z0:A8GZ ;\+$"  #B
M#   #0              @ &G#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    (
M /I!J%B7BKL<P    !,"   +              "  8,/  !?<F5L<R\N<F5L
M<U!+ 0(4 Q0    ( /I!J%BJQ"(6,P$  "("   /              "  6P0
M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #Z0:A8)!Z;HJT   #X 0
M&@              @ ',$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " #Z0:A899!YDAD!  #/ P  $P              @ &Q$@
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #[$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>imnn-20240503.xsd</File>
    <File>imnn-20240503_lab.xml</File>
    <File>imnn-20240503_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "IMNN",
   "nsuri": "http://imunon.com/20240503",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "imnn-20240503.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "imnn-20240503_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "imnn-20240503_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://imunon.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-05-03",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-05-03",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001493152-24-018166-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-018166-xbrl.zip
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M^MV#, *O-,;##\L&9FAMJ9)N= W2<<.L%=W$EE#1,J/!I/4;!GV]-JH^P>Q
MB^Z%1M6&4Q@4F&)3U+8C-M]3T*C!M$J2_1+6A.QVL+_)4',&ZKD<Q0V-?+(4
MLF"I<ICK@GT%V'?8HQR\C%JX3%28XV_]AE$_"@:S1.MAHA/KAK"NSPKQ(=B$
M@!^Q_>&\O/WEL><HR-PM*K!;Y'0TWSS&Y6IN?#$'.P,MCAALYJ@$>V4*ME5
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M01Z@ESN;=R(*)+Q2QW#)P+?@#[^AF!@%N,(E9JQ(,('_EL4=(9@Q1WQ!WH$
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M470MG,I:+IFAFO0AA?4BJ7_T>ZK!4H'GI##5O$#[21; S5A7*>ALD"Y9EDK
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M3G0I/<;/J\SK$O<+)6T?(N4BR72A$YD)R*&<-X5RAT_/-MV)H9MZQS_Q6KZ
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ML39(]@->C=44)D64 HB_%@<2I!N$+5Z<9AIY.+,(QJ%@S@%PX*XV6GEEX8J
MEYT?8VPA- E97QH]EJP43T0$94+4+$#7F5>250SEM$!ZNEY2'28VUXPW5O![
M_0\+^)]^7[S0*DOWQ24B^@$&((A,Z$71[\<V]^'H[&TMQEKA]4<JO,(K4F6;
M:\<993D[@Q^P-&<RG6(E-\/C\U/D0^?GE\/1Z.SBEY^WMK?X,\#]I/X<YXCC
M(0QDLG20I?[N !"9^AFM:OMO]^W/S54]QIP(-A7?HE*]*5>UG*D)OS&JWU@9
M^IXN<*W#FQ'U^Z_H/UH4OD(]]VAJ#!>Y[8><;1\83NIMU[%_#!)OL&+J2O*?
MTDS+U)Z2K07S^D)[Q1L>KP#QQ)Q"PAKB0ZOLVULMS%+IH%?7 ,Y"4JV*=X;X
MRE@%FFB<JK-VT'[+Y0P7 IE(*UO7P=HT$L!/">O9>7]GM]NIJ>"R5D>AB!Y8
MKYUI6AB7[U(..#3O5'GFJ_CVEG+L,%<)MD346&8T7V1GD:P-Q)F05'2PB'NA
M=A,B&?)F9L\QA[&:"QNM$$:\E]E<J+E0!E^OS[4SZV5,QD(HV2I,9@)K-E0?
M(9+HHA@R<P:T.]&QZN>)F6* IL33\'.'&*YF)H.;<SU$15E213D1J8D6215_
MA%-5.N8,7"&)&4XCUV/J_B5Q1IB<TO.0 ;P:# =L-:'10J5BC]UWG%*&7$0<
MTS.X4[I%,B/#6D1&")L/>:E<9-CZ-P45VUR3P%+"+2L_,Y1IYZ%:*(MN9W=[
M6\2L1@8:1\/M;9,;5"ZQNO24[H$LQJ*:PMP5E[THL<,'<,D^$5]UAPOO8'*@
MMJY-]W:WQ41;!YW&^9<2S0#[HH#W(?]SL/R&2U+&$QWWC&))P<+!)4%R<^4M
M<JQK YSQ8?E#C$#U/>I:!85)SA3QR#(W)4ZNLE#>?X&<#'B!*:" YQM,/+^6
M#NMP;"I//12JL&ST8C8<GNIS2=I]V*F.U<,BX,X];>IE[9A*.1:!)],F)(9-
M^<U32",FT."*Y6)&J&2EBZ8C 9^ON,V=8TY9:!>J=+&AK<!/)JK=8^9*.=Z@
MC#E&;@K9"<(IK65L#=).::U<D$2S"MJ@*@M5_*"/!(][[4/]B_H!&-=RP25<
M*1$_93+K=AAE\?2<;C(F!0[#M?Y8(=2NW;$/Y:_8M1>CBZ%H:3'*1\\LB<Z
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MOZ52A4)V3PDLIFJ?8N*:)*OPH)4;AWU.%926\0D1.JA(JZ2@0%]U41>K&J@
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MC^?T_XMS^I_C-'IMBT_I5P&&WPU(OT+P_P!02P,$%     @ ^D&H6+V-U!T
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MC:$TA;JP@9/@%(9\@K5#X\N5%!A*>TA(L  /B.Q'HHEC#2R%R@*U<1-DJWD
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MYH_ L6&/F()L\&TCT,"QFC[^!E!+ P04    " #Z0:A8+1,-B?T*  " A@
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MZCV>O *D:O!"W$4<RP.5EO]<)XP<@^VW:MW2U6&WR91%&!!)L#N GU+Y07]
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M,"TQ+FAT;5!+ 0(4 Q0    ( /I!J%@K/QW>/1$  $E0   *
M  "  39/  !E>#DY+3$N:'1M4$L! A0#%     @ ^D&H6+V-U!T &@  2K0
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8;6Q02P4&      8 !@!N 0  U)

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="imnn-20240503.xsd" xlink:type="simple"/>
    <context id="AsOf2024-05-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
        </entity>
        <period>
            <startDate>2024-05-03</startDate>
            <endDate>2024-05-03</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-05-03" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-05-03" id="Fact000004">0000749647</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-05-03" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-05-03" id="Fact000010">2024-05-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-05-03" id="Fact000011">IMUNON, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-05-03" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-05-03" id="Fact000013">001-15911</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-05-03" id="Fact000014">52-1256615</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-05-03" id="Fact000015">997     Lenox Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-05-03" id="Fact000016">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-05-03" id="Fact000017">Lawrenceville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-05-03" id="Fact000018">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-05-03" id="Fact000019">08648-2311</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-05-03" id="Fact000020">(609)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-05-03" id="Fact000021">896-9100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-05-03" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-05-03" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-05-03" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-05-03" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-05-03" id="Fact000026">Common stock, par value     $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-05-03" id="Fact000027">IMNN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-05-03" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-05-03" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
